000 | 01936 a2200529 4500 | ||
---|---|---|---|
005 | 20250515020859.0 | ||
264 | 0 | _c20060621 | |
008 | 200606s 0 0 eng d | ||
022 | _a0014-2999 | ||
024 | 7 |
_a10.1016/j.ejphar.2006.02.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTavridou, Anna | |
245 | 0 | 0 |
_aPharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesis. _h[electronic resource] |
260 |
_bEuropean journal of pharmacology _cMar 2006 |
||
300 |
_a34-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApolipoproteins B _xmetabolism |
650 | 0 | 4 |
_aBiological Transport _xdrug effects |
650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCholesterol _xbiosynthesis |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aFarnesyl-Diphosphate Farnesyltransferase _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLipids _xbiosynthesis |
650 | 0 | 4 |
_aLipoproteins, LDL _xpharmacokinetics |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
650 | 0 | 4 |
_aMorpholines _xpharmacology |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aReceptors, LDL _xmetabolism |
650 | 0 | 4 |
_aSimvastatin _xpharmacology |
650 | 0 | 4 |
_aTriglycerides _xbiosynthesis |
700 | 1 | _aKaklamanis, Loukas | |
700 | 1 | _aMegaritis, George | |
700 | 1 | _aKourounakis, Angeliki P | |
700 | 1 | _aPapalois, Apostolos | |
700 | 1 | _aRoukounas, Dimitris | |
700 | 1 | _aRekka, Eleni A | |
700 | 1 | _aKourounakis, Panos N | |
700 | 1 | _aCharalambous, Avgui | |
700 | 1 | _aManolopoulos, Vangelis G | |
773 | 0 |
_tEuropean journal of pharmacology _gvol. 535 _gno. 1-3 _gp. 34-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2006.02.006 _zAvailable from publisher's website |
999 |
_c16154047 _d16154047 |